alphaveVAISHALI₹8.59

Vaishali Pharma Limited

· Unclassified

Annual Quarterly₹ CrorePeersTEMBO TOTAL OSWALSEEDS GROBTEA BEARDSELL HINDCON CROWN ARTNIRMANMcap ₹56 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	—	—	108.8	107.9
Other Income	—	—	3.8	3.6
Total Income	—	—	112.6	111.5
Expenses
+ Purchases of Stock-in-Trade	—	—	93.7	92.2
+ Changes in Inventories	—	—	1.4	2.3
+ Employee Benefit Expense	—	—	2.9	2.8
+ Finance Costs	—	—	2.0	1.8
+ Depreciation & Amortisation	—	—	0.6	0.6
+ Other Expenses	—	—	6.6	6.3
Total Expenses	—	—	107.2	106.1
EBITDA	—	—	4.1	4.2
EBIT	—	—	3.5	3.6
Profit
PBT before Exceptional Items	—	—	5.4	5.4
Pretax Income	—	—	5.4	5.4
+ Current Tax	—	—	1.3	1.3
+ Deferred Tax	—	—	0.0	-0.1
Tax Expense	—	—	1.4	1.1
+ Share of Associates & JVs	—	—	0.1	0.2
Net Income	—	—	4.2	4.4
+ Net Income — Continuing Ops	—	—	4.0	4.2
+ Other Comprehensive Income	—	—	0.0	0.0
Total Comprehensive Income	—	—	4.2	4.5
Per Share
Basic EPS	—	—	0.32	0.34
Diluted EPS	—	—	0.32	0.34
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.0	—
+ Items NOT to be Reclassified to P&L	—	—	0.0	—
+ Tax on Items NOT to be Reclassified	—	—	0.0	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	—	—	0.32	0.34
Diluted EPS — Continuing Operations	—	—	0.32	0.34
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	—	—	13.6	13.4
Gross Margin %	—	—	12.55	12.40
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	—	—	5.4	5.4
Net Income Adj (tax-effected)	—	—	4.2	4.4
EPS Adj	—	—	0.32	0.34
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	—	—	2.00	2.00
Paid Up Equity Capital	—	—	13.0	13.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.